Antares Therapeutics
Antares Therapeutics is a Boston- and South San Francisco-based precision medicine company developing small-molecule therapies against validated but previously undruggable targets in cancer and other serious diseases. Spun out of Scorpion Therapeutics following Eli Lilly's March 2025 acquisition of Scorpion, Antares launched in June 2025 with a $177 million Series A co-led by Omega Funds, Atlas Venture, Lightspeed Venture Partners, BVF Partners and Cormorant Asset Management. The company combines medicinal chemistry (proprietary compound libraries and next-generation mass spectrometry to find new chemical pockets), target biology (first-in-class preclinically validated targets and allosteric approaches to clinically validated ones), and predictive sciences (physics-based modeling, machine learning and molecular dynamics) to shorten discovery cycles. Its most advanced program is expected to enter the clinic in 2026, with multiple additional preclinical programs and discovery collaborations with Novartis, AstraZeneca and Pierre Fabre Laboratories. Antares is a private, preclinical-stage biotechnology company and publishes no public product API, developer portal or SDK surface.
More than an index entry, but the surface is still mostly links rather than artifacts — the cohort most likely to move a full band from modest, well-targeted work.
API Evangelist profiles Antares Therapeutics the way a machine reads it — 4 machine-readable artifacts across 1 API, pulled from the provider's own public surface and indexed so a developer, an analyst, or an AI agent can evaluate it against every other provider on the network.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Antares Therapeutics scores 22.1/100 (emerging), with a separate agent-readiness read of 14/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
How we profile Antares Therapeutics
Each block below is one kind of artifact we hold for Antares Therapeutics. For each we say what it is and why it earns a place in the profile, then list every one we've indexed — capped at two rows, scroll within the panel for the rest.
APIs 1
Each API is captured as its own OpenAPI definition — every operation, parameter, and response. This is the single most useful machine-readable description of what an API does, and it's what lets us score, lint, mock, and generate against it without asking the provider for anything.
Individual APIs this provider publishes, each with its own machine-readable definition.
Antares Therapeutics WordPress REST API
The public WordPress REST API behind antaresrx.com. This is the content management surface for the corporate marketing site and its press-release / in-the-media newsroom -- it i...
Security Posture 3
Authentication, domain security, vulnerability disclosure, and trust-center signals — the evidence that a provider takes security seriously enough to document it. We profile it because you can't govern what you can't see.
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Every other property we hold for Antares Therapeutics — documentation, portals, status pages, policies, and corporate surface — grouped by the job it does, following the integrator's arc from getting started to running in production.
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 3
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 8
The organization behind the API
Scroll within the panel for all 8 ·
← All providers · Data indexed from github.com/api-evangelist/antares-therapeutics · machine-readable index on apis.io